Your browser doesn't support javascript.
loading
4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification.
Kiyuna, Ligia A; Candido, Darlan S; Bechara, Luiz R G; Jesus, Itamar C G; Ramalho, Lisley S; Krum, Barbara; Albuquerque, Ruda P; Campos, Juliane C; Bozi, Luiz H M; Zambelli, Vanessa O; Alves, Ariane N; Campolo, Nicolás; Mastrogiovanni, Mauricio; Bartesaghi, Silvina; Leyva, Alejandro; Durán, Rosario; Radi, Rafael; Arantes, Guilherme M; Cunha-Neto, Edécio; Mori, Marcelo A; Chen, Che-Hong; Yang, Wenjin; Mochly-Rosen, Daria; MacRae, Ian J; Ferreira, Ludmila R P; Ferreira, Julio C B.
  • Kiyuna LA; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Candido DS; Laboratory of Immunology, Heart Institute, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Bechara LRG; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Jesus ICG; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Ramalho LS; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Krum B; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Albuquerque RP; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Campos JC; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Bozi LHM; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415 - Butanta, 05508-000 São Paulo-SP, Brazil.
  • Zambelli VO; Laboratory of Pain and Signaling, Butantan Institute, São Paulo, Brazil.
  • Alves AN; Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, São Paulo, Brazil.
  • Campolo N; Departamento de Bioquímica and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República (UdelaR), Montevideo, Uruguay.
  • Mastrogiovanni M; Departamento de Bioquímica and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República (UdelaR), Montevideo, Uruguay.
  • Bartesaghi S; Departamento de Bioquímica and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República (UdelaR), Montevideo, Uruguay.
  • Leyva A; Unidad de Bioquímica y Proteómica Analítica (UByPA), Instituto de Investigaciones Biológicas Celemente Estable & Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Durán R; Unidad de Bioquímica y Proteómica Analítica (UByPA), Instituto de Investigaciones Biológicas Celemente Estable & Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Radi R; Departamento de Bioquímica and Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República (UdelaR), Montevideo, Uruguay.
  • Arantes GM; Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, São Paulo, Brazil.
  • Cunha-Neto E; Laboratory of Immunology, Heart Institute, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Mori MA; Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (Unicamp), São Paulo, Brazil.
  • Chen CH; Department of Chemical and Systems Biology, Stanford University School of Medicine, CCSR 3145A, 269 Campus Drive, Stanford, CA 94305, USA.
  • Yang W; Foresee Pharmaceuticals, Co., Ltd, Taipei, Taiwan.
  • Mochly-Rosen D; Department of Chemical and Systems Biology, Stanford University School of Medicine, CCSR 3145A, 269 Campus Drive, Stanford, CA 94305, USA.
  • MacRae IJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Ferreira LRP; Laboratory of Immunology, Heart Institute, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Ferreira JCB; Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil.
Eur Heart J ; 44(44): 4696-4712, 2023 Nov 21.
Article en En | MEDLINE | ID: mdl-37944136
ABSTRACT
BACKGROUND AND

AIMS:

Developing novel therapies to battle the global public health burden of heart failure remains challenging. This study investigates the underlying mechanisms and potential treatment for 4-hydroxynonenal (4-HNE) deleterious effects in heart failure.

METHODS:

Biochemical, functional, and histochemical measurements were applied to identify 4-HNE adducts in rat and human failing hearts. In vitro studies were performed to validate 4-HNE targets.

RESULTS:

4-HNE, a reactive aldehyde by-product of mitochondrial dysfunction in heart failure, covalently inhibits Dicer, an RNase III endonuclease essential for microRNA (miRNA) biogenesis. 4-HNE inhibition of Dicer impairs miRNA processing. Mechanistically, 4-HNE binds to recombinant human Dicer through an intermolecular interaction that disrupts both activity and stability of Dicer in a concentration- and time-dependent manner. Dithiothreitol neutralization of 4-HNE or replacing 4-HNE-targeted residues in Dicer prevents 4-HNE inhibition of Dicer in vitro. Interestingly, end-stage human failing hearts from three different heart failure aetiologies display defective 4-HNE clearance, decreased Dicer activity, and miRNA biogenesis impairment. Notably, boosting 4-HNE clearance through pharmacological re-activation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) using Alda-1 or its improved orally bioavailable derivative AD-9308 restores Dicer activity. ALDH2 is a major enzyme responsible for 4-HNE removal. Importantly, this response is accompanied by improved miRNA maturation and cardiac function/remodelling in a pre-clinical model of heart failure.

CONCLUSIONS:

4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Insuficiencia Cardíaca Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Insuficiencia Cardíaca Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article